Deloitte University Press
Navigate the Complex Issues
Deloitte has identified health care providers’ most critical challenges in navigating the path ahead. We offer a robust portfolio of solutions to help.
BioPharmaceuticals, medical technology and generics
Learn how Deloitte helps biopharmaceutical, medical technology and generics companies address the challenges and opportunities of the evolving US and global health care system.
Health Care Current: June 2, 2015
Analysts expect the worldwide biosimilars market to reach $25 to $35 billion by 2020. Is this new market a possible gold rush, or a misguided hunt for fool’s gold?